DOI: 10.1016/s1359-6446(04)03115-0. Compound lipophilicity for substrate binding to human P450s in drug metabolism

Compound lipophilicity for substrate binding to human P450s in drug metabolism

10.1016/s1359-6446(04)03115-0

Crossref journal-article

Elsevier BV

Drug Discovery Today (78)

Bibliography

Lewis, D. F. V., Jacobs, M. N., & Dickins, M. (2004). Compound lipophilicity for substrate binding to human P450s in drug metabolism. Drug Discovery Today, 9(12), 530â537.

Authors 3

David F.V. Lewis (first)
Miriam N. Jacobs (additional)
Maurice Dickins (additional)

References 61 Referenced 142

{'key': '10.1016/S1359-6446(04)03115-0_BIB1', 'series-title': 'Cytochromes P450: Structure, Function and Mechanism', 'author': 'Lewis', 'year': '1996'} / Cytochromes P450: Structure, Function and Mechanism by Lewis (1996)
{'key': '10.1016/S1359-6446(04)03115-0_BIB2', 'series-title': 'Guide to Cytochromes P450 Structure and Function', 'author': 'Lewis', 'year': '2001'} / Guide to Cytochromes P450 Structure and Function by Lewis (2001)
{'key': '10.1016/S1359-6446(04)03115-0_BIB3', 'first-page': '1', 'article-title': 'Forms and functions of cytochrome P450', 'volume': '121', 'author': 'Stegeman', 'year': '1998', 'journal-title': 'Comp. Biochem. Physiol. C'} / Comp. Biochem. Physiol. C / Forms and functions of cytochrome P450 by Stegeman (1998)
10.1081/DMR-120001392 / Drug Metab. Rev / Summary of information on human CYP enzymes: human P450 metabolism data by Rendic (2002)
10.3109/03602539709037591 / Drug Metab. Rev / Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors by Rendic (1997)
{'key': '10.1016/S1359-6446(04)03115-0_BIB6', 'first-page': '414', 'article-title': 'Inter-individual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians', 'volume': '270', 'author': 'Shimada', 'year': '1994', 'journal-title': 'J. Pharmacol. Exp. Ther'} / J. Pharmacol. Exp. Ther / Inter-individual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians by Shimada (1994)
10.1016/S0006-2952(98)00033-1 / Biochem. Pharmacol / Development of a comprehensive panel of antibodies against the major xenobiotic metabolizing forms of cytochrome P450 in humans by Edwards (1998)
10.2174/1389200023337522 / Curr. Drug Metab / Cytochrome P450 pharmacogenetics in drug development: in vitro studies and clinical consequences by Rodrigues (2002)
10.2174/0929867033456855 / Curr. Med. Chem / Human cytochromes P450 associated with the Phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families by Lewis (2003)
10.1016/0928-0987(94)90074-4 / Eur. J. Pharm. Sci / Chemistry and enzymology: their use in the prediction of human drug metabolism by Smith (1994)
10.1016/S1367-5931(99)80056-8 / Curr. Opin. Chem. Biol / Pharmacokinetics and metabolism in early drug discovery by Smith (1999)
10.1016/S1359-6446(97)01081-7 / Drug Discov. Today / Properties of cytochrome P450 isoenzymes and their substrates. Part 1: active site characteristics by Smith (1997)
10.1016/S1359-6446(97)01085-4 / Drug Discov. Today / Properties of cytochrome P450 isoenzymes and the substrates. Part 2: properties of cytochrome P450 substrates by Smith (1997)
10.1016/S1359-6446(02)02412-1 / Drug Discov. Today / Substrate SARs in human P450s by Lewis (2002)
10.1081/DMR-120018245 / Drug Metab. Rev / Baseline lipophilicity relationships in human cytochromes P450 associated with drug metabolism by Lewis (2003)
10.3109/03602539308993972 / Drug Metab. Rev / Quantitative structure-activity relationships of cytochrome P450 by Hansch (1993)
10.3109/03602539608994017 / Drug Metab. Rev / QSAR of P450 oxidation: on the value of comparing kcat and Km with kcat/Km by Gao (1996)
10.1289/ehp.971051204 / Environ. Health Perspect / Estimating xenobiotic half-lives in humans from rat data: influence of log P by Sarver (1997)
10.2174/1389200033489343 / Curr. Drug Metab / On the estimation of binding affinity (ΔGbind) for human P450 substrates by Lewis (2003)
10.1021/ar50020a002 / Acc. Chem. Res / A quantitative approach to biochemical structure-activity relationships by Hansch (1969)
10.1016/S1359-6446(03)02739-9 / Drug Discov. Today / Computational approaches to the understanding of ADMET properties and problems by Modi (2003)
10.1021/cr60274a001 / Chem. Rev / Partition coefficients and their uses by Leo (1971)
10.1021/jm000407e / J. Med. Chem / Property-based design: optimization of drug absorption and pharmacokinetics by van de Waterbeemd (2001)
10.1016/S1359-6446(03)02649-7 / Drug Discov. Today / Pharmaceutical profiling in drug discovery by Kerns (2003)
10.1016/S1359-6446(97)01099-4 / Drug Discov. Today / Managing the drug discovery/development interface by Kennedy (1997)
10.1021/ci990162i / J. Chem. Inf. Comput. Sci / The characterization of chemical structures using molecular properties: a survey by Livingstone (2000)
{'key': '10.1016/S1359-6446(04)03115-0_BIB27', 'first-page': '85', 'article-title': 'The parametrization of lipophilicity and other structural properties in drug design', 'volume': '16', 'author': 'van de Waterbeemd', 'year': '1987', 'journal-title': 'Adv. Drug Res'} / Adv. Drug Res / The parametrization of lipophilicity and other structural properties in drug design by van de Waterbeemd (1987)
10.1016/S1359-6446(97)01084-2 / Drug Discov. Today / QSAR and 3D QSAR in drug design. Part 2: applications and problems by Kubinyi (1997)
10.2174/1386207013330850 / Comb. Chem. High Throughput Screen / Prediction of intestinal absorption and blood-brain barrier penetration by computational methods by Clark (2001)
10.1021/tx015502k / Chem. Res. Toxicol / Parametrization of electrophilicity for the prediction of the toxicity of aromatic compounds by Cronin (2001)
10.1016/S0169-409X(96)00423-1 / Adv. Drug Deliv. Rev / Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting by Lipinski (1997)
10.1016/0006-2952(78)90521-X / Biochem. Pharmacol / The role of substrate lipophilicity in determining type 1 microsomal P450 binding characteristics by Al-Gailany (1978)
{'key': '10.1016/S1359-6446(04)03115-0_BIB33', 'first-page': '282', 'article-title': 'A comparison of the effectgs of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro', 'volume': '29', 'author': 'Ishigami', 'year': '2001', 'journal-title': 'Drug Metab. Dispos'} / Drug Metab. Dispos / A comparison of the effectgs of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro by Ishigami (2001)
10.1124/dmd.30.12.1497 / Drug Metab. Dispos / The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties by Austin (2002)
10.1023/A:1011085411050 / Pharm. Res / Development of a generalized, quantitative physicochemical model of CYP3A4 inhibition for use in early drug discovery by Riley (2001)
10.1111/j.1365-2672.1996.tb03224.x / J. Appl. Bacteriol / Quantitative structure-activity relationship for the effect of benzoic acids, cinnamic acids and benzaldehydes on Listeria monocytogenes by Ramos-Nino (1996)
10.1016/0024-3205(91)90341-8 / Life Sci / The role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitro by Ferrari (1991)
10.1042/bj2840483 / Biochem. J / Interaction of 7-n-alkoxycoumarins with cytochrome P4502 and their partitioning into liposomal membranes by Vermeir (1992)
10.1016/0005-2736(92)90333-H / Biochim. Biophys. Acta / Modelling of interaction of basic lipophilic ligands with cytochrome P450 reconstituted in liposomes. Determination of membrane partition coefficients of S(-)-nicotine and N,N-diethylaniline from spectral binding studies and fluorescence quenching by Vermeir (1992)
10.1081/DMR-100101942 / Drug Metab. Rev / The role of CYP2B6 in human xenobiotic metabolism by Ekins (1999)
{'key': '10.1016/S1359-6446(04)03115-0_BIB41', 'series-title': 'Substituent Constants for Correlation Analysis in Chemistry and Biology', 'author': 'Hansch', 'year': '1979'} / Substituent Constants for Correlation Analysis in Chemistry and Biology by Hansch (1979)
{'key': '10.1016/S1359-6446(04)03115-0_BIB42', 'series-title': 'Exploring QSAR 2. Hydrophobic, Electronic and Steric Constants', 'author': 'Hansch', 'year': '1995'} / Exploring QSAR 2. Hydrophobic, Electronic and Steric Constants by Hansch (1995)
10.1016/S1359-6446(02)02478-9 / Drug Discov. Today / Application of hydrogen bonding calculations in property based drug design by Abraham (2002)
Lewis, D.F.V. Hydrogen bonding in human P450-substrate interactions: a major contribution to binding affinity. Scientific World J. (in press) (10.1100/tsw.2004.210)
10.1100/tsw.2002.343 / Scientific World J / Molecular binding interactions: their estimation and rationalization of QSARs in terms of theoretically derived parameters by Lewis (2002)
10.1073/pnas.082522999 / Proc. Natl. Acad. Sci. U. S. A / Comparison of the dynamics of substrate access in three cytochrome P450s reveals different opening mechanisms and a novel functional role for a buried arginine by Winn (2002)
{'key': '10.1016/S1359-6446(04)03115-0_BIB47', 'first-page': '936', 'article-title': 'Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome P450 active sites', 'volume': '29', 'author': 'Ekins', 'year': '2001', 'journal-title': 'Drug Metab. Dispos'} / Drug Metab. Dispos / Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome P450 active sites by Ekins (2001)
10.1016/S0169-409X(02)00009-1 / Adv. Drug Deliv. Rev / Pharmacophore modeling of cytochromes P450 by de Groot (2002)
10.1016/S1359-6446(99)01451-8 / Drug Discov. Today / Computational methods for the prediction of ‘drug-likeness’ by Clark (2000)
10.1021/tx970210y / Chem. Res. Toxicol / Understanding and estimating membrane/water partition coefficients: approaches to derive quantitative structure property relationships by Vaes (1998)
10.1002/jps.2600840120 / J. Pharm. Sci / Atom/fragment contribution method for estimating octanol-water partition coefficients by Meylan (1995)
10.1248/cpb.40.127 / Chem. Pharm. Bull. (Tokyo) / Simple method of calculating octanol/water partition coefficient by Moriguchi (1992)
10.1248/cpb.42.976 / Chem. Pharm. Bull. (Tokyo) / Comparison of reliability of log P values for drugs calculated by several methods by Moriguchi (1994)
10.1021/jm0000822 / J. Med. Chem / ElogPoct: a tool for lipophilicity determination in drug discovery by Lombardo (2000)
{'key': '10.1016/S1359-6446(04)03115-0_BIB55', 'series-title': 'Lipophilicity in Drug Action and Toxicology', 'year': '1996'} / Lipophilicity in Drug Action and Toxicology (1996)
10.1063/1.555833 / J. Phys. Chem. Ref. Data / Octanol-water partition coefficients of simple organic compounds by Sangster (1989)
10.1039/b300574g / Analyst / Evaluation of a reversed-phase column (Supercosil LC-ABZ) under isocratic and gradient elution conditions for estimating octanol-water partition coefficients by Dias (2003)
10.1177/106002807801200906 / Drug Intell. Clin. Pharm / pKa values of medicinal compounds in pharmacy practice by Newton (1978)
{'key': '10.1016/S1359-6446(04)03115-0_BIB59', 'series-title': "Lange's Handbook of Chemistry", 'year': '1992'} / Lange's Handbook of Chemistry (1992)
10.1515/DMDI.2003.19.3.189 / Drug Metabol. Drug Interact / Molecular modelling of CYP2B6 based on homology with the CYP2C5 crystal structure: analysis of enzyme–substrate interactions by Lewis (2003)
10.1016/0022-2836(88)90471-8 / J. Mol. Biol / Aromatic rings act as hydrogen bond donors by Levitt (1988)

Dates

Type	When
Created	21 years, 2 months ago (June 15, 2004, 3:32 p.m.)
Deposited	6 years, 7 months ago (Feb. 6, 2019, 10:29 p.m.)
Indexed	1 week ago (Aug. 30, 2025, 12:23 p.m.)
Issued	21 years, 3 months ago (June 1, 2004)
Published	21 years, 3 months ago (June 1, 2004)
Published Print	21 years, 3 months ago (June 1, 2004)

Funders 0

None

BibTeX

@article{Lewis_2004, title={Compound lipophilicity for substrate binding to human P450s in drug metabolism}, volume={9}, ISSN={1359-6446}, url={http://dx.doi.org/10.1016/s1359-6446(04)03115-0}, DOI={10.1016/s1359-6446(04)03115-0}, number={12}, journal={Drug Discovery Today}, publisher={Elsevier BV}, author={Lewis, David F.V. and Jacobs, Miriam N. and Dickins, Maurice}, year={2004}, month=jun, pages={530–537} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        30
      ]
    ],
    "date-time": "2025-08-30T16:23:10Z",
    "timestamp": 1756570990095
  },
  "reference-count": 61,
  "publisher": "Elsevier BV",
  "issue": "12",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2004,
            6,
            1
          ]
        ],
        "date-time": "2004-06-01T00:00:00Z",
        "timestamp": 1086048000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2004,
        6
      ]
    ]
  },
  "DOI": "10.1016/s1359-6446(04)03115-0",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        6,
        15
      ]
    ],
    "date-time": "2004-06-15T19:32:24Z",
    "timestamp": 1087327944000
  },
  "page": "530-537",
  "source": "Crossref",
  "is-referenced-by-count": 142,
  "title": "Compound lipophilicity for substrate binding to human P450s in drug metabolism",
  "prefix": "10.1016",
  "volume": "9",
  "author": [
    {
      "given": "David F.V.",
      "family": "Lewis",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Miriam N.",
      "family": "Jacobs",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Maurice",
      "family": "Dickins",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB1",
      "series-title": "Cytochromes P450: Structure, Function and Mechanism",
      "author": "Lewis",
      "year": "1996"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB2",
      "series-title": "Guide to Cytochromes P450 Structure and Function",
      "author": "Lewis",
      "year": "2001"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB3",
      "first-page": "1",
      "article-title": "Forms and functions of cytochrome P450",
      "volume": "121",
      "author": "Stegeman",
      "year": "1998",
      "journal-title": "Comp. Biochem. Physiol. C"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB4",
      "doi-asserted-by": "crossref",
      "first-page": "83",
      "DOI": "10.1081/DMR-120001392",
      "article-title": "Summary of information on human CYP enzymes: human P450 metabolism data",
      "volume": "34",
      "author": "Rendic",
      "year": "2002",
      "journal-title": "Drug Metab. Rev"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "413",
      "DOI": "10.3109/03602539709037591",
      "article-title": "Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors",
      "volume": "29",
      "author": "Rendic",
      "year": "1997",
      "journal-title": "Drug Metab. Rev"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB6",
      "first-page": "414",
      "article-title": "Inter-individual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians",
      "volume": "270",
      "author": "Shimada",
      "year": "1994",
      "journal-title": "J. Pharmacol. Exp. Ther"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB7",
      "doi-asserted-by": "crossref",
      "first-page": "377",
      "DOI": "10.1016/S0006-2952(98)00033-1",
      "article-title": "Development of a comprehensive panel of antibodies against the major xenobiotic metabolizing forms of cytochrome P450 in humans",
      "volume": "56",
      "author": "Edwards",
      "year": "1998",
      "journal-title": "Biochem. Pharmacol"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB8",
      "doi-asserted-by": "crossref",
      "first-page": "289",
      "DOI": "10.2174/1389200023337522",
      "article-title": "Cytochrome P450 pharmacogenetics in drug development: in vitro studies and clinical consequences",
      "volume": "3",
      "author": "Rodrigues",
      "year": "2002",
      "journal-title": "Curr. Drug Metab"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB9",
      "doi-asserted-by": "crossref",
      "first-page": "1955",
      "DOI": "10.2174/0929867033456855",
      "article-title": "Human cytochromes P450 associated with the Phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families",
      "volume": "10",
      "author": "Lewis",
      "year": "2003",
      "journal-title": "Curr. Med. Chem"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB10",
      "doi-asserted-by": "crossref",
      "first-page": "69",
      "DOI": "10.1016/0928-0987(94)90074-4",
      "article-title": "Chemistry and enzymology: their use in the prediction of human drug metabolism",
      "volume": "2",
      "author": "Smith",
      "year": "1994",
      "journal-title": "Eur. J. Pharm. Sci"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB11",
      "doi-asserted-by": "crossref",
      "first-page": "373",
      "DOI": "10.1016/S1367-5931(99)80056-8",
      "article-title": "Pharmacokinetics and metabolism in early drug discovery",
      "volume": "3",
      "author": "Smith",
      "year": "1999",
      "journal-title": "Curr. Opin. Chem. Biol"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB12",
      "doi-asserted-by": "crossref",
      "first-page": "406",
      "DOI": "10.1016/S1359-6446(97)01081-7",
      "article-title": "Properties of cytochrome P450 isoenzymes and their substrates. Part 1: active site characteristics",
      "volume": "2",
      "author": "Smith",
      "year": "1997",
      "journal-title": "Drug Discov. Today"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB13",
      "doi-asserted-by": "crossref",
      "first-page": "479",
      "DOI": "10.1016/S1359-6446(97)01085-4",
      "article-title": "Properties of cytochrome P450 isoenzymes and the substrates. Part 2: properties of cytochrome P450 substrates",
      "volume": "2",
      "author": "Smith",
      "year": "1997",
      "journal-title": "Drug Discov. Today"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB14",
      "doi-asserted-by": "crossref",
      "first-page": "918",
      "DOI": "10.1016/S1359-6446(02)02412-1",
      "article-title": "Substrate SARs in human P450s",
      "volume": "7",
      "author": "Lewis",
      "year": "2002",
      "journal-title": "Drug Discov. Today"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB15",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1081/DMR-120018245",
      "article-title": "Baseline lipophilicity relationships in human cytochromes P450 associated with drug metabolism",
      "volume": "35",
      "author": "Lewis",
      "year": "2003",
      "journal-title": "Drug Metab. Rev"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB16",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.3109/03602539308993972",
      "article-title": "Quantitative structure-activity relationships of cytochrome P450",
      "volume": "25",
      "author": "Hansch",
      "year": "1993",
      "journal-title": "Drug Metab. Rev"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB17",
      "doi-asserted-by": "crossref",
      "first-page": "513",
      "DOI": "10.3109/03602539608994017",
      "article-title": "QSAR of P450 oxidation: on the value of comparing kcat and Km with kcat/Km",
      "volume": "28",
      "author": "Gao",
      "year": "1996",
      "journal-title": "Drug Metab. Rev"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB18",
      "doi-asserted-by": "crossref",
      "first-page": "1204",
      "DOI": "10.1289/ehp.971051204",
      "article-title": "Estimating xenobiotic half-lives in humans from rat data: influence of log P",
      "volume": "105",
      "author": "Sarver",
      "year": "1997",
      "journal-title": "Environ. Health Perspect"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB19",
      "doi-asserted-by": "crossref",
      "first-page": "331",
      "DOI": "10.2174/1389200033489343",
      "article-title": "On the estimation of binding affinity (\u0394Gbind) for human P450 substrates",
      "volume": "4",
      "author": "Lewis",
      "year": "2003",
      "journal-title": "Curr. Drug Metab"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB20",
      "doi-asserted-by": "crossref",
      "first-page": "232",
      "DOI": "10.1021/ar50020a002",
      "article-title": "A quantitative approach to biochemical structure-activity relationships",
      "volume": "2",
      "author": "Hansch",
      "year": "1969",
      "journal-title": "Acc. Chem. Res"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB21",
      "doi-asserted-by": "crossref",
      "first-page": "621",
      "DOI": "10.1016/S1359-6446(03)02739-9",
      "article-title": "Computational approaches to the understanding of ADMET properties and problems",
      "volume": "8",
      "author": "Modi",
      "year": "2003",
      "journal-title": "Drug Discov. Today"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB22",
      "doi-asserted-by": "crossref",
      "first-page": "525",
      "DOI": "10.1021/cr60274a001",
      "article-title": "Partition coefficients and their uses",
      "volume": "71",
      "author": "Leo",
      "year": "1971",
      "journal-title": "Chem. Rev"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB23",
      "doi-asserted-by": "crossref",
      "first-page": "1313",
      "DOI": "10.1021/jm000407e",
      "article-title": "Property-based design: optimization of drug absorption and pharmacokinetics",
      "volume": "44",
      "author": "van de Waterbeemd",
      "year": "2001",
      "journal-title": "J. Med. Chem"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB24",
      "doi-asserted-by": "crossref",
      "first-page": "316",
      "DOI": "10.1016/S1359-6446(03)02649-7",
      "article-title": "Pharmaceutical profiling in drug discovery",
      "volume": "8",
      "author": "Kerns",
      "year": "2003",
      "journal-title": "Drug Discov. Today"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB25",
      "doi-asserted-by": "crossref",
      "first-page": "436",
      "DOI": "10.1016/S1359-6446(97)01099-4",
      "article-title": "Managing the drug discovery/development interface",
      "volume": "2",
      "author": "Kennedy",
      "year": "1997",
      "journal-title": "Drug Discov. Today"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB26",
      "doi-asserted-by": "crossref",
      "first-page": "195",
      "DOI": "10.1021/ci990162i",
      "article-title": "The characterization of chemical structures using molecular properties: a survey",
      "volume": "40",
      "author": "Livingstone",
      "year": "2000",
      "journal-title": "J. Chem. Inf. Comput. Sci"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB27",
      "first-page": "85",
      "article-title": "The parametrization of lipophilicity and other structural properties in drug design",
      "volume": "16",
      "author": "van de Waterbeemd",
      "year": "1987",
      "journal-title": "Adv. Drug Res"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB28",
      "doi-asserted-by": "crossref",
      "first-page": "538",
      "DOI": "10.1016/S1359-6446(97)01084-2",
      "article-title": "QSAR and 3D QSAR in drug design. Part 2: applications and problems",
      "volume": "2",
      "author": "Kubinyi",
      "year": "1997",
      "journal-title": "Drug Discov. Today"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB29",
      "doi-asserted-by": "crossref",
      "first-page": "477",
      "DOI": "10.2174/1386207013330850",
      "article-title": "Prediction of intestinal absorption and blood-brain barrier penetration by computational methods",
      "volume": "4",
      "author": "Clark",
      "year": "2001",
      "journal-title": "Comb. Chem. High Throughput Screen"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB30",
      "doi-asserted-by": "crossref",
      "first-page": "1498",
      "DOI": "10.1021/tx015502k",
      "article-title": "Parametrization of electrophilicity for the prediction of the toxicity of aromatic compounds",
      "volume": "14",
      "author": "Cronin",
      "year": "2001",
      "journal-title": "Chem. Res. Toxicol"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB31",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "DOI": "10.1016/S0169-409X(96)00423-1",
      "article-title": "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting",
      "volume": "23",
      "author": "Lipinski",
      "year": "1997",
      "journal-title": "Adv. Drug Deliv. Rev"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB32",
      "doi-asserted-by": "crossref",
      "first-page": "783",
      "DOI": "10.1016/0006-2952(78)90521-X",
      "article-title": "The role of substrate lipophilicity in determining type 1 microsomal P450 binding characteristics",
      "volume": "27",
      "author": "Al-Gailany",
      "year": "1978",
      "journal-title": "Biochem. Pharmacol"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB33",
      "first-page": "282",
      "article-title": "A comparison of the effectgs of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro",
      "volume": "29",
      "author": "Ishigami",
      "year": "2001",
      "journal-title": "Drug Metab. Dispos"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB34",
      "doi-asserted-by": "crossref",
      "first-page": "1497",
      "DOI": "10.1124/dmd.30.12.1497",
      "article-title": "The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties",
      "volume": "30",
      "author": "Austin",
      "year": "2002",
      "journal-title": "Drug Metab. Dispos"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB35",
      "doi-asserted-by": "crossref",
      "first-page": "652",
      "DOI": "10.1023/A:1011085411050",
      "article-title": "Development of a generalized, quantitative physicochemical model of CYP3A4 inhibition for use in early drug discovery",
      "volume": "18",
      "author": "Riley",
      "year": "2001",
      "journal-title": "Pharm. Res"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB36",
      "doi-asserted-by": "crossref",
      "first-page": "303",
      "DOI": "10.1111/j.1365-2672.1996.tb03224.x",
      "article-title": "Quantitative structure-activity relationship for the effect of benzoic acids, cinnamic acids and benzaldehydes on Listeria monocytogenes",
      "volume": "80",
      "author": "Ramos-Nino",
      "year": "1996",
      "journal-title": "J. Appl. Bacteriol"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB37",
      "doi-asserted-by": "crossref",
      "first-page": "2259",
      "DOI": "10.1016/0024-3205(91)90341-8",
      "article-title": "The role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitro",
      "volume": "48",
      "author": "Ferrari",
      "year": "1991",
      "journal-title": "Life Sci"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB38",
      "doi-asserted-by": "crossref",
      "first-page": "483",
      "DOI": "10.1042/bj2840483",
      "article-title": "Interaction of 7-n-alkoxycoumarins with cytochrome P4502 and their partitioning into liposomal membranes",
      "volume": "284",
      "author": "Vermeir",
      "year": "1992",
      "journal-title": "Biochem. J"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB39",
      "doi-asserted-by": "crossref",
      "first-page": "93",
      "DOI": "10.1016/0005-2736(92)90333-H",
      "article-title": "Modelling of interaction of basic lipophilic ligands with cytochrome P450 reconstituted in liposomes. Determination of membrane partition coefficients of S(-)-nicotine and N,N-diethylaniline from spectral binding studies and fluorescence quenching",
      "volume": "1107",
      "author": "Vermeir",
      "year": "1992",
      "journal-title": "Biochim. Biophys. Acta"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB40",
      "doi-asserted-by": "crossref",
      "first-page": "719",
      "DOI": "10.1081/DMR-100101942",
      "article-title": "The role of CYP2B6 in human xenobiotic metabolism",
      "volume": "31",
      "author": "Ekins",
      "year": "1999",
      "journal-title": "Drug Metab. Rev"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB41",
      "series-title": "Substituent Constants for Correlation Analysis in Chemistry and Biology",
      "author": "Hansch",
      "year": "1979"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB42",
      "series-title": "Exploring QSAR 2. Hydrophobic, Electronic and Steric Constants",
      "author": "Hansch",
      "year": "1995"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB43",
      "doi-asserted-by": "crossref",
      "first-page": "1056",
      "DOI": "10.1016/S1359-6446(02)02478-9",
      "article-title": "Application of hydrogen bonding calculations in property based drug design",
      "volume": "7",
      "author": "Abraham",
      "year": "2002",
      "journal-title": "Drug Discov. Today"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB44",
      "doi-asserted-by": "crossref",
      "unstructured": "Lewis, D.F.V. Hydrogen bonding in human P450-substrate interactions: a major contribution to binding affinity. Scientific World J. (in press)",
      "DOI": "10.1100/tsw.2004.210"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB45",
      "doi-asserted-by": "crossref",
      "first-page": "1776",
      "DOI": "10.1100/tsw.2002.343",
      "article-title": "Molecular binding interactions: their estimation and rationalization of QSARs in terms of theoretically derived parameters",
      "volume": "2",
      "author": "Lewis",
      "year": "2002",
      "journal-title": "Scientific World J"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB46",
      "doi-asserted-by": "crossref",
      "first-page": "5361",
      "DOI": "10.1073/pnas.082522999",
      "article-title": "Comparison of the dynamics of substrate access in three cytochrome P450s reveals different opening mechanisms and a novel functional role for a buried arginine",
      "volume": "99",
      "author": "Winn",
      "year": "2002",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB47",
      "first-page": "936",
      "article-title": "Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome P450 active sites",
      "volume": "29",
      "author": "Ekins",
      "year": "2001",
      "journal-title": "Drug Metab. Dispos"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB48",
      "doi-asserted-by": "crossref",
      "first-page": "367",
      "DOI": "10.1016/S0169-409X(02)00009-1",
      "article-title": "Pharmacophore modeling of cytochromes P450",
      "volume": "54",
      "author": "de Groot",
      "year": "2002",
      "journal-title": "Adv. Drug Deliv. Rev"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB49",
      "doi-asserted-by": "crossref",
      "first-page": "49",
      "DOI": "10.1016/S1359-6446(99)01451-8",
      "article-title": "Computational methods for the prediction of \u2018drug-likeness\u2019",
      "volume": "5",
      "author": "Clark",
      "year": "2000",
      "journal-title": "Drug Discov. Today"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB50",
      "doi-asserted-by": "crossref",
      "first-page": "847",
      "DOI": "10.1021/tx970210y",
      "article-title": "Understanding and estimating membrane/water partition coefficients: approaches to derive quantitative structure property relationships",
      "volume": "11",
      "author": "Vaes",
      "year": "1998",
      "journal-title": "Chem. Res. Toxicol"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB51",
      "doi-asserted-by": "crossref",
      "first-page": "83",
      "DOI": "10.1002/jps.2600840120",
      "article-title": "Atom/fragment contribution method for estimating octanol-water partition coefficients",
      "volume": "84",
      "author": "Meylan",
      "year": "1995",
      "journal-title": "J. Pharm. Sci"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB52",
      "doi-asserted-by": "crossref",
      "first-page": "127",
      "DOI": "10.1248/cpb.40.127",
      "article-title": "Simple method of calculating octanol/water partition coefficient",
      "volume": "40",
      "author": "Moriguchi",
      "year": "1992",
      "journal-title": "Chem. Pharm. Bull. (Tokyo)"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB53",
      "doi-asserted-by": "crossref",
      "first-page": "976",
      "DOI": "10.1248/cpb.42.976",
      "article-title": "Comparison of reliability of log P values for drugs calculated by several methods",
      "volume": "42",
      "author": "Moriguchi",
      "year": "1994",
      "journal-title": "Chem. Pharm. Bull. (Tokyo)"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB54",
      "doi-asserted-by": "crossref",
      "first-page": "2922",
      "DOI": "10.1021/jm0000822",
      "article-title": "ElogPoct: a tool for lipophilicity determination in drug discovery",
      "volume": "43",
      "author": "Lombardo",
      "year": "2000",
      "journal-title": "J. Med. Chem"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB55",
      "series-title": "Lipophilicity in Drug Action and Toxicology",
      "year": "1996"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB56",
      "doi-asserted-by": "crossref",
      "first-page": "1111",
      "DOI": "10.1063/1.555833",
      "article-title": "Octanol-water partition coefficients of simple organic compounds",
      "volume": "18",
      "author": "Sangster",
      "year": "1989",
      "journal-title": "J. Phys. Chem. Ref. Data"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB57",
      "doi-asserted-by": "crossref",
      "first-page": "427",
      "DOI": "10.1039/b300574g",
      "article-title": "Evaluation of a reversed-phase column (Supercosil LC-ABZ) under isocratic and gradient elution conditions for estimating octanol-water partition coefficients",
      "volume": "128",
      "author": "Dias",
      "year": "2003",
      "journal-title": "Analyst"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB58",
      "doi-asserted-by": "crossref",
      "first-page": "546",
      "DOI": "10.1177/106002807801200906",
      "article-title": "pKa values of medicinal compounds in pharmacy practice",
      "volume": "12",
      "author": "Newton",
      "year": "1978",
      "journal-title": "Drug Intell. Clin. Pharm"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB59",
      "series-title": "Lange's Handbook of Chemistry",
      "year": "1992"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB60",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "DOI": "10.1515/DMDI.2003.19.3.189",
      "article-title": "Molecular modelling of CYP2B6 based on homology with the CYP2C5 crystal structure: analysis of enzyme\u2013substrate interactions",
      "volume": "19",
      "author": "Lewis",
      "year": "2003",
      "journal-title": "Drug Metabol. Drug Interact"
    },
    {
      "key": "10.1016/S1359-6446(04)03115-0_BIB61",
      "doi-asserted-by": "crossref",
      "first-page": "751",
      "DOI": "10.1016/0022-2836(88)90471-8",
      "article-title": "Aromatic rings act as hydrogen bond donors",
      "volume": "201",
      "author": "Levitt",
      "year": "1988",
      "journal-title": "J. Mol. Biol"
    }
  ],
  "container-title": "Drug Discovery Today",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1359644604031150?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1359644604031150?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        2,
        7
      ]
    ],
    "date-time": "2019-02-07T03:29:59Z",
    "timestamp": 1549510199000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1359644604031150"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2004,
        6
      ]
    ]
  },
  "references-count": 61,
  "journal-issue": {
    "issue": "12",
    "published-print": {
      "date-parts": [
        [
          2004,
          6
        ]
      ]
    }
  },
  "alternative-id": [
    "S1359644604031150"
  ],
  "URL": "http://dx.doi.org/10.1016/S1359-6446(04)03115-0",
  "relation": {},
  "ISSN": [
    "1359-6446"
  ],
  "subject": [],
  "container-title-short": "Drug Discovery Today",
  "published": {
    "date-parts": [
      [
        2004,
        6
      ]
    ]
  }
}